Affiliation:
1. Shanghai EpimAb Biotherapeutics Co., LTD , 6F, Building 2, 4560 Jinke Road, Shanghai 201203 , China
Abstract
Abstract
Bispecific antibodies (bsAbs) are often composed of more than two component chains, such as Fabs-in-tandem immunoglobin (FIT-Ig) comprising three different component chains, which bring challenges for generating a high proportion of the correctly assembled bsAbs in a stable cell line. During the CHO-K1 stable cell line construction of a FIT-Ig, we investigated the FIT-Ig component chain ratio in transfection, where two sets of expression vectors were designed. Both designs utilized two vectors for co-transfection. Multiple transfections with plasmid ratio adjustment were applied, and the resultant minipools were evaluated for expression titer and quality of produced FIT-Ig. The results suggested that abundant outer Fab short chains (twofold chain genes versus other chains) can promote complete FIT-Ig assembly and therefore reduce the fragmental impurities of FIT-Ig. This adjustment of the component chain ratios at the beginning is beneficial to FIT-Ig stable cell line generation and brings favorable clones to process development.
Funder
Shanghai EpimAb Biotherapeutics Co., LTD
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference22 articles.
1. Multispecific drugs herald a new era of biopharmaceutical innovation;Deshaies;Nature,2020
2. Biology drives the discovery of bispecific antibodies as innovative therapeutics;Nie;Antib Ther,2020
3. Bispecific antibodies: a mechanistic review of the pipeline;Reichert;Nat Rev Drug Discov,2019
4. Mosunetuzumab: first approval;Kang;Drugs,2022
5. Faricimab: first approval;Shirley;Drugs,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献